Turn Therapeutics Inc. Common Stock (TTRX) — Cash Flow Quality Index
Latest as of December 2025:
-4.21x
Turn Therapeutics Inc. Common Stock (TTRX) has a Cash Flow Quality Index of -4.21x as of December 2025. Operating cash flow of $-1.18 Million is below net income of $279.07K, suggesting accrual-heavy earnings not yet converted to cash. Also explore Turn Therapeutics Inc. Common Stock (TTRX) total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
-4.21x
Operating CF / Net Income
Operating Cash Flow
$-1.18 Million
USD
Net Income
$279.07K
USD
Data as of
Dec 2025
Most recent filing
Annual Cash Flow Quality Index for Turn Therapeutics Inc. Common Stock (None–None)
Year-by-year earnings quality comparison for Turn Therapeutics Inc. Common Stock. For live market cap and the full company financial profile, see Turn Therapeutics Inc. Common Stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.